Evidence map›Paper›PMID 36970468›Full record

ArticleACS catalysis2023

A Cold-Active Flavin-Dependent Monooxygenase from

Andrea M Chánique, Nakia Polidori, Lucija Sovic, Daniel Kracher, Leen Assil-Companioni, Philipp Galuska, Loreto P Parra, Karl Gruber, Robert Kourist

Open access · hybridFull text read
In one paragraph

Article in ACS catalysis, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Andrea M ChániqueNAWI Graz, BioTechMed-Graz, Institute of Molecular Biotechnology, Graz University of Technology, Petersgasse 14, Graz 8010, Austria.
Nakia PolidoriNAWI Graz, BioTechMed Graz, Institute of Molecular Biosciences, University of Graz, Humboldtstraße 50, Graz 8010, Austria.ORCID https://orcid.org/0000-0003-0361-3091
Lucija SovicNAWI Graz, BioTechMed-Graz, Institute of Molecular Biotechnology, Graz University of Technology, Petersgasse 14, Graz 8010, Austria.
Daniel KracherNAWI Graz, BioTechMed-Graz, Institute of Molecular Biotechnology, Graz University of Technology, Petersgasse 14, Graz 8010, Austria.
Leen Assil-CompanioniNAWI Graz, BioTechMed-Graz, Institute of Molecular Biotechnology, Graz University of Technology, Petersgasse 14, Graz 8010, Austria.
Philipp GaluskaNAWI Graz, BioTechMed Graz, Institute of Molecular Biosciences, University of Graz, Humboldtstraße 50, Graz 8010, Austria.
Loreto P ParraSchools of Engineering, Medicine and Biological Sciences, Institute for Biological and Medical Engineering, Pontificia Universidad Católica de Chile, Vicuña Mackenna 4860, Santiago 7810000, Chile.
Karl GruberNAWI Graz, BioTechMed Graz, Institute of Molecular Biosciences, University of Graz, Humboldtstraße 50, Graz 8010, Austria.ORCID https://orcid.org/0000-0002-3485-9740
Robert KouristNAWI Graz, BioTechMed-Graz, Institute of Molecular Biotechnology, Graz University of Technology, Petersgasse 14, Graz 8010, Austria.ORCID https://orcid.org/0000-0002-2853-3525
Institute of Molecular Biotechnology · ATUniversity of Graz · ATPontificia Universidad Católica de Chile · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cold-active enzymes maintain a large part of their optimal activity at low temperatures. Therefore, they can be used to avoid side reactions and preserve heat-sensitive compounds. Baeyer-Villiger monooxygenases (BVMO) utilize molecular oxygen as a co-substrate to catalyze reactions widely employed for steroid, agrochemical, antibiotic, and pheromone production. Oxygen has been described as the rate-limiting factor for some BVMO applications, thereby hindering their efficient utilization. Considering that oxygen solubility in water increases by 40% when the temperature is decreased from 30 to 10 °C, we set out to identify and characterize a cold-active BVMO. Using genome mining in the Antarctic organism

Identifiers

PMID36970468
PMCPMC10028610
OpenAlexW4322493647

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read191
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.